v3.26.3
Schedule of Research and Development (Details) - Chemomab Therapeutics Ltd [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Consultants and subcontractors $ 644 $ 817 $ 1,076 $ 2,572 $ 3,640 $ 7,994 $ 14,014
Salaries and related expenses 432 459 862 1,085 1,848 2,715 3,362
Lease and maintenance 11 31 22 58 79 101 137
Share-based compensation 37 (39) 79 22 158 401 407
Other expenses 18 19 28 43 108 116 461
Total $ 1,142 $ 1,287 $ 2,067 $ 3,780 $ 5,833 [1] $ 11,327 [1] $ 18,381 [1]
[1] Includes expenses related to related parties of $1,014 thousand, $1,228 thousand and $1,324 thousand for the years ended December 31, 2025, 2024 and 2023, respectively. See Note 12.